These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 23929039)

  • 1. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.
    Bandapalli OR; Macher-Goeppinger S; Schirmacher P; Brand K
    Clin Exp Metastasis; 2012 Jun; 29(5):409-17. PubMed ID: 22362252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.
    Lee JI; Wright JH; Johnson MM; Bauer RL; Sorg K; Yuen S; Hayes BJ; Nguyen L; Riehle KJ; Campbell JS
    Am J Physiol Cell Physiol; 2016 Mar; 310(6):C436-45. PubMed ID: 26632601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
    Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
    Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.
    Campbell JS; Hughes SD; Gilbertson DG; Palmer TE; Holdren MS; Haran AC; Odell MM; Bauer RL; Ren HP; Haugen HS; Yeh MM; Fausto N
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3389-94. PubMed ID: 15728360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting stromal cells for the treatment of platelet-derived growth factor C-induced hepatocellular carcinogenesis.
    Campbell JS; Johnson MM; Bauer RL; Hudkins KL; Gilbertson DG; Riehle KJ; Yeh MM; Alpers CE; Fausto N
    Differentiation; 2007 Nov; 75(9):843-52. PubMed ID: 17999742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells.
    Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY
    Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development.
    Okada H; Honda M; Campbell JS; Sakai Y; Yamashita T; Takebuchi Y; Hada K; Shirasaki T; Takabatake R; Nakamura M; Sunagozaka H; Tanaka T; Fausto N; Kaneko S
    Cancer Res; 2012 Sep; 72(17):4459-71. PubMed ID: 22651928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
    Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
    Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
    Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
    J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
    Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
    Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation.
    Giraudi PJ; Becerra VJ; Marin V; Chavez-Tapia NC; Tiribelli C; Rosso N
    Exp Mol Pathol; 2015 Feb; 98(1):85-92. PubMed ID: 25533546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
    Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
    BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29.
    Kwiecinski M; Elfimova N; Noetel A; Töx U; Steffen HM; Hacker U; Nischt R; Dienes HP; Odenthal M
    Lab Invest; 2012 Jul; 92(7):978-87. PubMed ID: 22565577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.